(Q34019616)

30 July 2017

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry (English)

1 reference

30 July 2017

1

Jan Beyer-Westendorf

1 reference

30 July 2017

Kati Förster

2

1 reference

30 July 2017

Sven Pannach

3

1 reference

30 July 2017

Franziska Ebertz

4

1 reference

30 July 2017

Vera Gelbricht

5

1 reference

30 July 2017

Christoph Thieme

6

1 reference

30 July 2017

Franziska Michalski

7

1 reference

30 July 2017

Christina Köhler

8

1 reference

30 July 2017

Sebastian Werth

9

1 reference

30 July 2017

Kurtulus Sahin

10

1 reference

30 July 2017

Luise Tittl

11

1 reference

30 July 2017

Ulrike Hänsel

12

1 reference

30 July 2017

Norbert Weiss

13

1 reference

30 July 2017

language of work or name

English

0 references

publication date

23 May 2014

1 reference

30 July 2017

1 reference

30 July 2017

124

1 reference

30 July 2017

6

1 reference

30 July 2017

955-962

1 reference

Management and outcomes of major bleeding during treatment with dabigatran or warfarin

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Rates of hemorrhage during warfarin therapy for atrial fibrillation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Anticoagulation-related intracranial hemorrhages

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Oral rivaroxaban for symptomatic venous thromboembolism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Effect of study setting on anticoagulation control: a systematic review and metaregression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Hospitalization for vitamin-K-antagonist-related bleeding: treatment patterns and outcome

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126334

Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota

29 October 2018

1 reference

12 December 2020

Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists

1 reference

12 December 2020

Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin

1 reference

12 December 2020

Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding

1 reference

12 December 2020

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

1 reference

12 December 2020

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

1 reference

12 December 2020

10.1182/BLOOD-2014-03-563577

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference